Category: Company News
-
Anavex Life Sciences Advances Alzheimer’s Phase 3 Planning as Cash Runway Extends Into Fiscal 2028
Anavex Life Sciences (NASDAQ:AVXL) is advancing Alzheimer’s Phase 3 planning with the FDA after submitting its clinical trial data to a newly opened Alzheimer’s IND, while reporting $118.3 million in cash and an expected operating runway into mid to late fiscal 2028. Key Investor Takeaways Why AVXL Stock Is in Focus Anavex’s near-term regulatory strategy…
-
Lavish Enterprises Introduces FleetPath Ace Autonomous Trucking Operator Ahead of Beta Testing
Lavish Enterprises (USOTC:VXIT) has introduced FleetPath Ace, an autonomous trucking operator designed to perform defined operational tasks across dispatch, billing, safety, maintenance, finance and other carrier functions, with live autonomous execution planned as part of FleetPath’s beta rollout. Key Investor Takeaways Why VXIT Stock Is in Focus FleetPath Ace represents an expansion of FleetPath from…
-
Hyperscale Data Bitcoin Treasury Reaches Approximately $21.6 Million
Hyperscale Data (AMEX:GPUS) reported 278.0314 Bitcoin valued at approximately $21.6 million as of August 23, 2026, while making no open-market Bitcoin purchases or sales during the latest week. Key Investor Takeaways Why GPUS Stock Is in Focus Hyperscale Data said its wholly owned subsidiaries Sentinum and Ault Capital Group collectively held 278.0314 Bitcoin as of…
-
American Fusion Reaches 100 Pending Patent Applications for Texatron Fusion Platform
American Fusion Inc. (USOTC:AMFN) has reached 100 pending patent applications covering its Texatron Fusion Engine platform after filing 17 additional U.S. applications, expanding the intellectual property portfolio surrounding its developing fusion technology. The latest filings focus largely on aluminum-based configurations and alternative structural designs, extending protection across areas including fusion-confinement structures, toroidal chambers, fuel-injection systems,…
-
Xeriant Positions NexBoard as Universal Construction Panel After Independent Testing
Xeriant, Inc. (USOTC:XERI) is positioning its NexBoard composite panel as a universal construction material capable of replacing several traditional building products after independent laboratory testing showed performance advantages across multiple categories. The company says NexBoard could potentially serve applications ranging from interior walls and ceilings to subflooring, roofing underlayment and exterior sheathing, broadening the commercial…
-
American EcoFuels Launches Phase 2 Patent Expansion for GTL and CTL Technologies
American EcoFuels Inc. (USOTC:AEFI) has launched a Phase 2 patent expansion programme that currently contemplates up to 584 additional applications covering its Gas-to-Liquids and Coal-to-Liquids technology platforms. The intellectual property initiative is designed to broaden protection around the company’s synthetic fuel technologies as American EcoFuels advances toward engineering, testing, certification and potential commercialisation of Sustainable…
-
Kraig Biocraft Laboratories Boosts Spider Silk Production More Than 30% During Rainy Season
Kraig Biocraft Laboratories, Inc. (USOTC:KBLB) has increased spider silk production by more than 30% from its previous record, achieving the higher output during the rainy season despite constraints on the availability of usable mulberry feedstock. The production record provides another operational test for Kraig Labs as it works toward commercial-scale spider silk manufacturing, while management…
-
Eva Live Expands Into International Gaming Through Majority-Owned IGA
Eva Live Inc. (NASDAQ:GOAI) is expanding into international gaming and lottery operations through its 60% ownership of International Gaming Alliance, which has signed a three-year Master Services Agreement with Lottery.com International Limited. The agreement gives Eva Live a majority-owned platform spanning approved activities across Canada, Central America, South America, Southeast Asia and West Africa, while…
-
Capricor Therapeutics Deramiocel PDUFA Date Extended to November as FDA Reviews BLA Amendment
Capricor Therapeutics (NASDAQ:CAPR) faces a three-month extension to the FDA review timeline for Deramiocel after the agency moved the PDUFA target action date for the Duchenne muscular dystrophy cell therapy from August 22 to November 22, 2026. The extension follows Capricor’s submission of a major amendment containing 24-month open-label extension data from the Phase 3…
-
BTC Digital Georgia 10MW Cryptocurrency Computing Project Nears Deployment Readiness
BTC Digital Ltd. (NASDAQ:BTCT) has completed construction of its 10-megawatt cryptocurrency computing infrastructure project in Georgia, with the facility expected to become ready for mining machine deployment and the start of digital asset mining operations within approximately two months. At full deployment, the site is designed to support up to approximately 900,000 TH/s, or 900…